Intramuscular botulinum toxin a (BTXA) in complex regional pain syndrome

Pain Physician

Volumn 14, Issue 3, 2011, Pages 311-316

  Kharkar, Siddharth ^a   Ambady, Prakash ^a   Yedatore, Venkatesh ^a   Schwartzman, Robert ^a  

^a HAHNEMANN UNIVERSITY HOSPITAL   (United States)

Author keywords

Botulinum toxin; Complex regional pain syndrome; Dystonia; Spasm

Indexed keywords

BOTULINUM TOXIN A;

ANALGESIA; ARM MUSCLE; BRACE; CLINICAL ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; DRUG INDUCED DISEASE; DYSPHAGIA; DYSTONIA; ELECTROMYOGRAPHY; FEMALE; HUMAN; MALE; MUSCLE SPASM; NECK SPASM; PAIN ASSESSMENT; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; TRANSIENT NECK DROP; TREATMENT RESPONSE;

BOTULINUM TOXINS, TYPE A; COMPLEX REGIONAL PAIN SYNDROMES; DYSTONIC DISORDERS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES; SPASM;

EID: 79957799823     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Schwartzman RJ, Erwin KL, Alexander GM. The natural history of complex regional pain syndrome. Clin J Pain 2009; 25:273-280.
2. Birklein F. Complex regional pain syndrome. J Neurol 2005; 252:131-138.
3. Schwartzman RJ, Alexander GM, Gro-thusen J. Pathophysiology of complex regional pain syndrome. Expert Rev Neu-rother 2006; 6:669-681.
4. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 2005; 26:785-793.
5. Park HJ, Lee Y, Lee J, Park C, Moon DE. The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain. Can J Anaesth 2006; 53:470-477.
6. Ranoux D, Attal N, Morain F, Bouhas-sira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008; 64:274-283.
7. Casale R, Tugnoli V. Botulinum toxin for pain. Drugs R D 2008; 9:11-27.
8. Raj PP. Botulinum neurotoxin in chronic pain management. Pain Pract 2004; 4:S68-S72.
9. Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botuli-num toxin A reduces formalin-induced pain. Pain 2004; 107:125-133.
10. Argoff CE. A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain 2002; 18:S177-S181.
11. Stanton-Hicks M, Jänig W, Hassen-busch S, Haddox JD, Boas R, Wilson P. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 1995; 63:127-133.
12. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94:149-158.
13. Woolf CJ, Salter MW. Neuronal plasticity: Increasing the gain in pain. Science 2000; 288:1765-1769.
14. Kilo S, Harding-Rose C, Hargreaves KM, Flores CM. Peripheral CGRP release as a marker for neurogenic inflammation: A model system for the study of neuro-peptide secretion in rat paw skin. Pain 1997; 73:201-207.
15. Duggan MJ, Quinn CP, Chaddock JA, Purkiss JR, Alexander FCG, Doward S, Fooks SJ, Friis LM, Hall YHJ, Kirby ER, Leeds N, Moulsdale HJ, Dickenson A, Green GM, Rahman W, Suzuki R, Shone CC, Foster KA. Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clos-tridium botulinum toxin A endopepti-dase fragment and Erythrina cristagalli lectin. J Biol Chem 2002; 277:34846-34852.
16. Purkiss J, Welch M, Doward S, Foster K. Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. Biochem Pharmacol 2000; 59:1403-1406.
17. Meng J, Wang J, Lawrence G, Dolly JO. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J Cell Sci 2007; 120:2864-2874.
18. van Hilten JJ, van de Beek WJ, Vein AA, van Dijk JG, Middelkoop HA. Clinical aspects of multifocal or generalized tonic dystonia in reflex sympathetic dystrophy. Neurology 2001; 56:1762-1765.
19. Schwartzman RJ, Kerrigan J. The movement disorder of reflex sympathetic dystrophy. Neurology 1990; 40:57-61.
20. van Hilten BJ, van de Beek WJ, Hoff JI, Voormolen JH, Delhaas EM. Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med 2000; 343:625-630.
21. van Rijn MA, Munts AG, Marinus J, Voor-molen JHC, de Boer KS, Teepe-Twiss IM, van Dasselaar NT, Delhaas EM, van Hilten JJ. Intrathecal baclofen for dysto-nia of complex regional pain syndrome. Pain 2009; 143:41-47.
22. Munts AG, van der Plas AA, Voormolen JH, Marinus J, Teepe-Twiss IM, Onken-hout W, van Gerven JM, van Hilten JJ. In-trathecal glycine for pain and dystonia in complex regional pain syndrome. Pain 2009; 146:199-204.
23. Tugnoli V, Capone JG, Eleopra R, Qua-trale R, Sensi M, Gastaldo E, Tola MR, Geppetti P. Botulinum toxin type A reduces capsaicin-evoked pain and neuro-genic vasodilatation in human skin. Pain 2007; 130:76-83.
24. Gazerani P, Pedersen NS, Staahl C, Drewes AM, Arendt-Nielsen L. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain 2009; 141:60-69.
25. Carmichael NME, Dostrovsky JO, Charl-ton MP. Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin. Pain 2010; 149:316-324.
26. Yuan RY, Sheu JJ, Yu JM, Chen WT, Tseng IJ, Chang HH, Hu CJ. Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial. Neurology 2009; 72:1473-1478.
27. Jeynes LC, Gauci CA. Evidence for the use of botulinum toxin in the chronic pain setting--a review of the literature. Pain Pract 2008; 8:269-276.
28. Safarpour D, Jabbari B. Botulinum toxin A (botox) for treatment of proximal myofascial pain in complex regional pain syndrome: Two cases. Pain Med 2010; 11:1415-1418.
29. Safarpour D, Salardini A, Richardson D, Jabbari B. Botulinum Toxin A for Treatment of Allodynia of Complex Regional Pain Syndrome: A Pilot Study. Pain Med 2010; 11:1411-1414.
30. Carroll I, Clark JD, Mackey S. Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Ann Neurol 2009; 65:348-351.
31. Lauretti GR, Veloso FDS, Mattos ALD. [Functional rehabilitation and analgesia with botulinum toxin A in upper limb complex regional pain syndrome type I: case reports.]. Rev Bras Anestesiol 2005; 55:207-211.
32. Sigtermans MJ, van Hilten JJ, Bauer MCR, Arbous MS, Marinus J, Sarton EY, Dahan A. Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 2009; 145:304-311.
33. Kiefer RT, Rohr P, Ploppa A, Dieterich HJ, Grothusen J, Koffler S, Altemeyer KH, Unertl K, Schwartzman RJ. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: An open-label phase II study. Pain Med 2008; 9:1173-1120